Abstract:The parasite species formerly known as Plasmodium ovale , Plasmodium ovalecurtisi ( P . ovalecurtisi ) and Plasmodium ovalewallikeri ( P . ovalewallikeri ), are endemic across multiple African countries. These species are thought to differ in clinical symptomatology and latency, but only a small number of existing diagnostic assays can detect and distinguish them. In this study, we sought to develop new assays for the detection and differentiation of P . ovalecurtisi and P . ovalewallikeri by leveraging recently published whole-genome sequences for both species. Repetitive sequence motifs were identified in available P . ovalecurtisi and P . ovalewallikeri genomes and used for assay development and validation. We evaluated the analytical sensitivity of the best-performing singleplex and duplex assays using synthetic plasmids. We then evaluated the specificity of the duplex assay using a panel of samples from Tanzania and the Democratic Republic of the Congo (DRC), and validated its performance using 55 P . ovale samples and 40 non-ovale Plasmodium samples from the DRC. The best-performing P . ovalecurtisi and P . ovalewallikeri targets had 9 and 8 copies within the reference genomes, respectively. The P . ovalecurtisi assay had high sensitivity with a 95% confidence lower limit of detection (LOD) of 3.6 parasite genome equivalents/μl, while the P . ovalewallikeri assay had a 95% confidence LOD of 25.9 parasite genome equivalents/μl. A duplex assay targeting both species had 100% specificity and 95% confidence LOD of 4.2 and 41.2 parasite genome equivalents/μl for P . ovalecurtisi and P . ovalewallikeri , respectively. We identified promising multi-copy targets for molecular detection and differentiation of P . ovalecurtisi and P . ovalewallikeri and used them to develop real-time PCR assays. The best performing P . ovalecurtisi assay performed well in singleplex and duplex formats, while the P . ovalewallikeri assay did not reliably detect low-density infections in either format. These assays have potential use for high-throughput identification of P . ovalecurtisi , or for identification of higher density P . ovalecurtisi or P . ovalewallikeri infections that are amenable to downstream next-generation sequencing. Non-falciparum malaria appears to be on the rise, especially in settings where P . falciparum transmission is declining. Plasmodium ovalecurtisi and Plasmodium ovalewallikeri are neglected parasites that can cause relapsing malaria and are thought to differ in clinical symptomatology and latency. However, only few existing diagnostic assays can detect and distinguish them. Most target the 18S rRNA gene of both P . ovalecurtisi and P . ovalewallikeri with potential for cross-reactivity at higher parasite densities, and are not well-suited for high-throughput use, hindering our understanding of their epidemiology. Mining recently available P . ovalecurtisi and P . ovalewallikeri reference genomes, we identify new multi-copy targets for molecular detection and develop novel singleplex and duplex real-time PCR assays capable of species differentiation. These assays are highly specific and require short turn-around time. The P . ovalecurtisi assay performed well, while the P . ovalewallikeri assay did not reliably detect low-density infections. These assays provide new options for high-throughput studies of P . ovalecurtisi infection, as well as identification of higher density infections amenable to next-generation sequencing of both species.

Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream

Improved NAAT assay for the diagnosis of onchocerciasis and its use for detection of circulating cell free DNA

A Nested Real-Time Pcr Assay for the Quantification of Plasmodium Falciparum Dna Extracted from Dried Blood Spots

Comparison of diagnostic tools to assess the feasibility of programmatic use of rapid diagnostic tests for onchocerciasis: A dataset from Gabon

LupiQuant: A real-time PCR based assay for determining host-to-parasite DNA ratios of Onchocerca lupi and host Canis lupus from onchocercosis samples

Identification and Characterization of Onchocerca volvulus Heat Shock Protein 70 (OvHSP70) as Novel Diagnostic Marker of Onchocerciasis in Human Urine

Development of an indirect ELISA for the serodiagnosis of canine infection by Onchocerca lupi

Dermacase. Can you identify this condition? Nevus anemicus.

Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents

Performance evaluation of nine reference centers for effective surveillance of -infected Phlebotomine sand flies and basis for technical recommendations

Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale

The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date

Development and validation of a long-read metabarcoding platform for the detection of filarial worm pathogens of animals and humans

Instrument-Free Point-of-Care Diagnostic for Leishmania Parasites

Theobromine Intoxication in a Red Fox and a European Badger in Sweden

High-Sensitivity RT-LAMP for Molecular Detection of O'nyong-nyong (Alphavirus onyong)

[Chordoid glioma of the III ventricle. Case report and revision of the literature].

Real-time multiplex PCR for human echinococcosis and differential diagnosis

A pilot study demonstrating the identification of Trypanosoma brucei gambiense and T. b. rhodesiense in vectors using a multiplexed high-resolution melt qPCR

Development of a recombinase polymerase amplification (RPA) fluorescence assay for the detection of Schistosoma haematobium

Development of Loop-Mediated Isothermal Amplification Combined with Lateral Flow Dipstick Assay for a Rapid and Sensitive Detection of Cystic Echinococcosis in Livestock in Kenya